Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATADAR: Atazanavir/r vs Darunavir/r in Naïve HIV-1 Patients
NCT01274780Phase 4Completed
- Start
- May 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atazanavir and darunavir in human immunodeficiency virus type 1 infection (HIV-1). Started May 2011; status: completed.
02
Drugs
atazanavirdarunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01274780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274780.